Examkin

Patient Management

2074 soru

Tüm türler2,074Çoktan seçmeli1,048Çoklu seçim393Eşleştirme221Sıralama412
Soru 61Soru →

A 2828-year-old man is admitted to the intensive care unit with diabetic ketoacidosis. He is initially started on a continuous intravenous regular insulin infusion and 0.9%0.9\% normal saline. Over the next several hours, his blood glucose decreases from 550550 mg/dL to 220220 mg/dL. However, his calculated anion gap remains elevated at 1818 mEq/L, and his serum bicarbonate is 1414 mEq/L. He is clinically stable, and his mental status is improving.

Arrange the following subsequent management and monitoring steps in the correct chronological order to safely resolve the ketoacidosis and transition his therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first add dextrose to the IV fluids, then verify resolution of the anion gap, administer subcutaneous insulin, maintain a 11- to 22-hour overlap with the IV insulin, and finally discontinue the IV insulin.
The chronological management of diabetic ketoacidosis (DKA) focuses first on clearing ketoacids, which requires continuous insulin. When glucose falls below 200200-250250 mg/dL but the anion gap remains elevated, dextrose must be added to the IV fluids so insulin can be continued without causing hypoglycemia. Once the anion gap closes (≤12\leq 12 mEq/L), DKA is considered resolved. At this point, if the patient can tolerate oral intake, subcutaneous insulin is administered. Because IV insulin has a half-life of only a few minutes and subcutaneous insulin requires 11-22 hours for systemic absorption, the IV infusion must be continued for a 11- to 22-hour overlap period. Only after this overlap can the IV insulin be safely discontinued. Failing to overlap correctly is a major cause of rebound DKA in the hospital setting.

Adım Adım Çözüm

1
Evaluate the current metabolic parameters and adjust intravenous fluids.
Recognize that blood glucose has dropped below 250250 mg/dL but ketoacidosis persists (anion gap >12> 12 mEq/L). Dextrose is added to the IV fluids to prevent hypoglycemia while maintaining the insulin drip.
Continuous insulin is required to halt lipolysis and clear ketones; it cannot be stopped or significantly decreased based solely on glucose levels.
2
Monitor serial laboratory values until metabolic resolution is achieved.
Confirm that the anion gap has closed (≤12\leq 12 mEq/L) and bicarbonate has normalized (≥15\geq 15 mEq/L).
This indicates the underlying ketoacidosis has resolved, allowing for the safe transition to maintenance therapy.
3
Initiate the transition to subcutaneous insulin.
Administer a dose of long-acting subcutaneous basal insulin.
Subcutaneous insulin must be on board before the IV insulin is withdrawn to maintain basal metabolic control.
4
Overlap therapies to ensure continuous insulin coverage.
Continue the IV regular insulin infusion for 11 to 22 hours after the subcutaneous injection.
Subcutaneous insulin has a delayed onset of action. An overlap prevents a period of absolute insulin deficiency that could trigger rebound ketoacidosis.
5
Finalize the transition.
Discontinue the IV regular insulin infusion.
The subcutaneous insulin has now reached therapeutic levels, providing safe and continuous coverage.

Anahtar Kavram

Successful management of diabetic ketoacidosis requires maintaining an insulin infusion until the anion gap closes (adding dextrose if glucose falls prematurely) and ensuring a 11- to 22-hour overlap when transitioning to subcutaneous insulin to prevent rebound ketoacidosis.
Soru 62Soru →

Assign the most appropriate guideline-directed next step in the diagnostic sequence for each of the following patients presenting with clinical indicators of secondary hypertension.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 34-year-old woman evaluated for new-onset blood pressure of 165/105 mmHg, accompanied by recurrent headaches and pulsatile tinnitus. Physical examination reveals a right-sided cervical bruit. Her basic metabolic panel is unremarkable.
A 48-year-old man with persistently elevated blood pressure (158/98 mmHg) despite adherence to a regimen of amlodipine, lisinopril, and chlorthalidone. Laboratory evaluation shows a serum potassium of 3.2 mEq/L, a plasma aldosterone concentration of 28 ng/dL, and a plasma renin activity of 0.2 ng/mL/h.
A 55-year-old woman reporting paroxysmal episodes of severe diaphoresis, palpitations, and blood pressure spikes. Biochemical screening indicates 24-hour urine fractionated metanephrines that are five times the upper limit of normal.
A 62-year-old man with established primary hyperaldosteronism, confirmed via an oral sodium loading test, who is being evaluated for surgical intervention. An adrenal-protocol computed tomography scan demonstrates a 1.2 cm nodule in the right adrenal gland and a 1.4 cm nodule in the left adrenal gland.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match the 34-year-old woman with CTA of the renal arteries; the 48-year-old man with the intravenous isotonic saline infusion test; the 55-year-old woman with an MRI of the abdomen; and the 62-year-old man with bilateral adrenal venous sampling.
The correct diagnostic sequencing in secondary hypertension relies on a tiered approach: 1) Clinical or basic laboratory suspicion triggers targeted screening. 2) Positive screening for endocrine causes (like primary aldosteronism) requires definitive biochemical confirmation. 3) Following confirmation, anatomical localization (imaging) is performed. 4) If imaging is equivocal or shows bilateral disease in a surgical candidate, functional lateralization (e.g., venous sampling) is required. Vascular causes like FMD bypass endocrine testing and proceed directly to vascular imaging (CTA/MRA).

Adım Adım Çözüm

1
Evaluate the 34-year-old woman with bruits and tinnitus.
Identify high pre-test probability for Fibromuscular Dysplasia (FMD).
Vascular abnormalities in FMD require direct visualization of the renal arteries via CTA or MRA to assess for stenosis.
2
Analyze the 48-year-old man's hypokalemia and elevated aldosterone-to-renin ratio (ARR).
Identify a positive screening test for primary hyperaldosteronism.
Guidelines mandate biochemical confirmation (e.g., saline suppression test) before imaging, due to the high prevalence of non-secreting adrenal incidentalomas.
3
Assess the 55-year-old woman with elevated metanephrines.
Confirm the diagnosis of pheochromocytoma.
Once the biochemical diagnosis is definitively established, anatomical localization with abdominal MRI or CT is the next sequential step.
4
Review the 62-year-old man's confirmed hyperaldosteronism and bilateral nodules.
Identify the need to differentiate bilateral hyperplasia from a unilateral adenoma.
Because adrenal incidentalomas are common in older adults, bilateral adrenal venous sampling is necessary to confirm functional lateralization before considering unilateral adrenalectomy.

Anahtar Kavram

Strict adherence to diagnostic sequencing in secondary hypertension prevents premature closure and inappropriate surgical interventions, specifically by ensuring biochemical confirmation precedes anatomical imaging, and functional lateralization precedes surgery.

Alternatif Yöntem

For the patient with suspected primary hyperaldosteronism, an oral sodium loading test, fludrocortisone suppression test, or captopril challenge test are valid physiological alternatives to the intravenous saline infusion test for biochemical confirmation.
Tahmini Süre:2m 30s
Soru 63Soru →

A 74-year-old man is evaluated in the intensive care unit 24 hours after admission for a head injury sustained in a ground-level fall. His past medical history is significant for paroxysmal atrial fibrillation, heart failure with preserved ejection fraction, hypertension, and osteoarthritis. His home medications include dabigatran, amiodarone, lisinopril, and meloxicam.

On arrival yesterday, his Glasgow Coma Scale (GCS) score was 14. A noncontrast CT of the head revealed a 6-mm acute right-sided subdural hematoma without midline shift. Initial laboratory studies showed an activated partial thromboplastin time (aPTT) of 68 seconds (reference: 25-35 seconds) and a serum creatinine of 1.6 mg/dL (baseline 1.1 mg/dL). He was promptly administered 5 g of intravenous idarucizumab. A repeat head CT performed 6 hours post-admission showed no expansion of the hematoma.

Currently, the patient is alert and oriented (GCS 15) with no focal neurological deficits. His blood pressure is 132/84 mm Hg, and his pulse is 72/min and irregularly irregular.

Morning laboratory results are as follows:
Hemoglobin: 12.1 g/dL (unchanged from admission)
Platelet count: 185,000/mm³
Serum creatinine: 1.4 mg/dL
Prothrombin time: 13 seconds
Activated partial thromboplastin time (aPTT): 46 seconds

Which of the following is the most appropriate next step in the management of this patient's anticoagulation status?

Cevabı ve açıklamayı göster

Cevap: Continue clinical observation and serial neurological examinations

Cevap

Continue clinical observation and serial neurological examinations.
The correct answer is to continue clinical observation and serial neurological examinations. This patient presented with a life-threatening acute subdural hematoma while taking dabigatran, a direct thrombin inhibitor. The initial administration of idarucizumab, a humanized monoclonal antibody fragment that binds dabigatran with high affinity, successfully neutralized the plasma anticoagulant effect and halted hematoma expansion. At 24 hours post-administration, the patient is clinically stable with an unchanged hemoglobin and a normal neurological examination. The newly elevated aPTT of 46 seconds represents a well-documented phenomenon of 'rebound anticoagulation.' Because dabigatran has a large volume of distribution, extravascular drug slowly redistributes back into the plasma after the initial plasma pool is neutralized by idarucizumab. This redistribution often causes a prolonged aPTT or dilute thrombin time 12 to 24 hours after the reversal agent is given. However, routine re-administration of idarucizumab is not recommended for isolated laboratory rebound; a second dose is only indicated if the patient develops recurrent, life-threatening bleeding or requires an emergent surgical intervention. Careful clinical monitoring is the standard of care.

Adım Adım Çözüm

1
Assess the patient's current clinical stability and bleeding status.
The patient has a stable Glasgow Coma Scale of 15, no hematoma expansion on the 6-hour interval CT, and stable hemoglobin levels.
Clinical status determines whether abnormal coagulation tests represent a risk of future bleeding or active, ongoing hemorrhage requiring immediate intervention.
2
Evaluate the 24-hour laboratory parameters in the context of recent idarucizumab administration.
The aPTT has rebounded to 46 seconds (elevated from normal, but lower than the admission value of 68 seconds).
Understanding the pharmacokinetics of idarucizumab is required to interpret this lab value correctly.
3
Correlate the pharmacokinetic principles of dabigatran and its reversal agent.
Dabigatran has a large volume of distribution. Idarucizumab clears dabigatran from the plasma, but extravascular dabigatran can redistribute back into the plasma 12 to 24 hours later, causing a rebound prolongation of aPTT or thrombin time.
This confirms that the prolonged aPTT is an expected physiological redistribution rather than failure of the initial reversal.
4
Determine the appropriate management for an asymptomatic lab abnormality in this setting.
No further pharmacologic reversal is indicated; supportive care and serial monitoring should be maintained.
Treating a rebound laboratory value in the absence of clinical bleeding exposes the patient to unnecessary medical interventions and potential prothrombotic risks.

Anahtar Kavram

Following dabigatran reversal with idarucizumab, redistribution of extravascular dabigatran back into the systemic circulation commonly causes a rebound prolongation of the aPTT and thrombin time at 12 to 24 hours; in the absence of active bleeding, this isolated laboratory finding requires only clinical observation.
Soru 64Soru →

Review the following four patients currently undergoing evaluation in the emergency department. Utilizing standard objective clinical risk stratification pathways, match each patient's clinical presentation to their most appropriate initial disposition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

74-year-old patient presenting with a productive cough and fever. Examination reveals disorientation to time. Vital signs show a blood pressure of 85/50 mm Hg, heart rate of 110/min, and respiratory rate of 32/min. Laboratory results include a blood urea nitrogen of 28 mg/dL.
48-year-old patient presenting with intermittent, pressure-like chest pain. Past medical history is significant for hypertension. Electrocardiogram reveals 1-mm T-wave inversions in leads II, III, and aVF. Initial high-sensitivity troponin assay is within normal limits.
52-year-old patient diagnosed with an acute segmental pulmonary embolism via computed tomography angiography. Vital signs are stable, including an oxygen saturation of 97% on room air. The patient has no history of cardiopulmonary disease or malignancy.
66-year-old patient presenting with two episodes of melena. Vital signs show a blood pressure of 115/75 mm Hg and heart rate of 105/min. Laboratory results reveal a hemoglobin of 9.2 g/dL and blood urea nitrogen of 35 mg/dL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patients are best assigned as follows: the patient with pneumonia to the Intensive Care Unit, the patient with chest pain to the Clinical Observation Unit, the patient with pulmonary embolism to home discharge, and the patient with a gastrointestinal bleed to the General Medical Ward.
Correct disposition requires matching the objective severity of a patient's illness with the capabilities of a specific care setting. The Intensive Care Unit is reserved for patients with impending physiologic collapse (CURB-65 of 5). The Clinical Observation Unit safely houses moderate-risk patients needing brief, protocolized workups (HEART score of 4). Home discharge is optimized for patients whose acute pathology is stable and manageable with oral regimens (sPESI of 0). The General Medical Ward is utilized for patients requiring inpatient interventions who are not in immediate threat of hemodynamic collapse (stable upper gastrointestinal bleed).

Adım Adım Çözüm

1
Calculate the CURB-65 score for the 74-year-old patient with pneumonia.
The score is 5, indicating high severity.
To identify the need for critical care due to a high mortality risk associated with severe community-acquired pneumonia and active hypotension.
2
Calculate the HEART score for the 48-year-old patient with chest pain.
The score is 4, placing the patient in a moderate-risk category.
To prevent premature discharge of a patient who requires serial monitoring and potentially further ischemic evaluation.
3
Evaluate the 52-year-old patient with a pulmonary embolism using the simplified PESI criteria.
The sPESI score is 0, indicating low risk.
To safely avoid unnecessary hospitalization for a stable patient who can be managed outpatient with oral anticoagulation.
4
Calculate the Glasgow-Blatchford Score for the 66-year-old patient with a gastrointestinal bleed.
The score is elevated, requiring admission, but the patient remains hemodynamically stable.
To ensure the patient receives necessary inpatient endoscopic evaluation while avoiding over-utilization of the ICU.

Anahtar Kavram

Objective risk stratification scores (e.g., CURB-65, HEART, sPESI, Glasgow-Blatchford) guide safe and resource-efficient care setting transitions from the emergency department.
Soru 65Soru →

A 28-year-old woman arrives at the emergency department due to severe, progressive right lower quadrant abdominal pain over the past 12 hours, accompanied by nausea and vomiting. Vital signs show a temperature of 38.3°C (100.9°F), blood pressure of 112/72 mmHg, and pulse of 105/min. Physical examination demonstrates localized rigidity and rebound tenderness in the right lower quadrant. A complete blood count reveals a leukocyte count of 16,000/mm³. Cross-sectional imaging of the abdomen and pelvis confirms acute, uncomplicated appendicitis. The surgical team schedules an urgent laparoscopic appendectomy. Which of the following interventions are appropriate in the immediate preoperative management of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Administration of isotonic intravenous fluids; Administration of broad-spectrum intravenous antibiotics

Cevap

The appropriate interventions are the administration of isotonic intravenous fluids and the administration of broad-spectrum intravenous antibiotics.
The correct interventions are the administration of isotonic intravenous fluids and broad-spectrum intravenous antibiotics. In a patient presenting with acute appendicitis and clinical signs of volume depletion (vomiting, tachycardia, fever), immediate preoperative management must prioritize hemodynamic stabilization with intravenous fluids. Additionally, broad-spectrum antibiotics covering gastrointestinal flora (gram-negative rods and anaerobes) are the standard of care to prevent surgical site infections and control the underlying infection before the primary incision.

Adım Adım Çözüm

1
Identify the diagnosis and clinical status.
The patient has confirmed acute appendicitis and exhibits signs of mild volume depletion (tachycardia, vomiting, and fever).
Establishing the clinical baseline guides the immediate preoperative requirements.
2
Determine required preoperative interventions.
The patient requires prompt volume resuscitation and infection control.
To optimize the patient for safe surgical and anesthetic management.
3
Evaluate potential contraindications and avoid unnecessary steps.
Avoid therapeutic anticoagulation, redundant imaging, and inappropriate discharge.
To prevent complications such as severe hemorrhage, disease progression, or delayed care.

Anahtar Kavram

Essential preoperative management for urgent abdominal surgery (e.g., acute appendicitis) includes prompt fluid resuscitation and administration of prophylactic broad-spectrum intravenous antibiotics.
Tahmini Süre:1m 0s
Soru 66Soru →

Evaluation is underway for a patient hospitalized on the medical ward who is recovering from an exacerbation of chronic obstructive pulmonary disease. The patient, who has a past medical history of heart failure with preserved ejection fraction, paroxysmal atrial fibrillation, and major depressive disorder, was initially treated with intravenous methylprednisolone and continuous nebulized albuterol. His symptoms have significantly improved, and he is now breathing comfortably on room air.

His home medications, which were continued during the admission, include diltiazem, apixaban, escitalopram, and atorvastatin. Morning laboratory results are notable for a serum potassium level of 3.1 mEq/L3.1 \text{ mEq/L} and a serum magnesium level of 1.6 mg/dL1.6 \text{ mg/dL}. A routine 12-lead electrocardiogram performed today shows normal sinus rhythm with a QTc interval of 530 milliseconds530 \text{ milliseconds}. Before the planned discharge, a sputum polymerase chain reaction panel returns positive for Mycoplasma pneumoniae, prompting the decision to initiate targeted oral antibiotic therapy.

Which of the following is the most appropriate antimicrobial regimen to prescribe for this patient?

Cevabı ve açıklamayı göster

Cevap: Oral doxycycline

Cevap

The correct answer is oral doxycycline.
The correct answer is oral doxycycline. This patient requires targeted antibiotic therapy for an atypical pneumonia caused by Mycoplasma pneumoniae. The standard treatment options for atypical respiratory pathogens include macrolides, fluoroquinolones, and tetracyclines. However, this patient has multiple major risk factors for drug-induced Torsades de Pointes: a critically prolonged baseline QTc interval of 530 milliseconds530 \text{ milliseconds}, uncorrected hypokalemia and hypomagnesemia, and concurrent therapy with escitalopram, which is also known to prolong the QT interval. Doxycycline provides excellent antimicrobial coverage for Mycoplasma species and does not prolong the QT interval. Furthermore, doxycycline does not exhibit dangerous pharmacokinetic interactions with the patient's other high-risk medications, such as apixaban and diltiazem, making it the safest and most effective pharmacologic choice.

Adım Adım Çözüm

1
Identify the primary diagnosis and the targeted organism.
The patient has a confirmed Mycoplasma pneumoniae infection superimposed on a chronic obstructive pulmonary disease exacerbation.
The positive sputum polymerase chain reaction indicates an atypical bacterial infection requiring specific antimicrobial coverage.
2
Determine the standard treatment options for the identified pathogen.
Mycoplasma pneumoniae is typically treated with macrolides (e.g., azithromycin, clarithromycin), fluoroquinolones (e.g., levofloxacin, moxifloxacin), or tetracyclines (e.g., doxycycline).
These classes of antibiotics are active against cell-wall deficient atypical organisms.
3
Analyze the patient's baseline risk factors and current medication list.
The patient has a severely prolonged QTc interval (530 ms530 \text{ ms}), uncorrected hypokalemia (3.1 mEq/L3.1 \text{ mEq/L}), hypomagnesemia (1.6 mg/dL1.6 \text{ mg/dL}), and is taking escitalopram.
Identifying contraindications is crucial before prescribing new medications to avoid life-threatening adverse drug events.
4
Evaluate the safety profile of the potential antibiotics.
Macrolides and fluoroquinolones are absolutely contraindicated due to their potential to further prolong the QT interval and trigger Torsades de Pointes.
Doxycycline is the only appropriate agent from the list that does not carry the risk of QT prolongation.

Anahtar Kavram

Doxycycline is the preferred antibiotic for treating atypical pneumonia in patients with a prolonged QTc interval or taking QT-prolonging medications, as it lacks the arrhythmogenic risks associated with macrolides and fluoroquinolones.
Soru 67Soru →

A 62-year-old man is brought to the emergency department by emergency medical services (EMS) due to the sudden onset of difficulty breathing, facial swelling, and a diffuse pruritic rash. The symptoms began 15 minutes ago while he was eating at a seafood restaurant. His medical history is significant for hypertension, coronary artery disease, and heart failure with preserved ejection fraction. His home medications include lisinopril, metoprolol, aspirin, and atorvastatin. Upon arrival, his blood pressure is 74/40 mm Hg, pulse is 62/min, and oxygen saturation is 90% on room air. Physical examination reveals marked angioedema of the lips, widespread urticaria, and diffuse bilateral expiratory wheezing. EMS has established peripheral intravenous access.

Arrange the following pharmacologic interventions in the correct sequential order of administration for the acute escalation of therapy in this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Administer intramuscular epinephrine, 2) Administer a rapid intravenous bolus of 0.9% sodium chloride, 3) Administer intravenous glucagon, 4) Initiate a continuous intravenous epinephrine infusion.
The correct sequential management for severe anaphylactic shock in a patient taking beta-blockers follows a distinct escalation pathway. First, intramuscular epinephrine is the absolute first-line therapy and must never be delayed. Second, for persistent hypotension, aggressive intravenous fluid resuscitation with isotonic crystalloids (0.9% sodium chloride) is the next immediate step to counteract massive vasodilation and capillary leak. Third, because this patient is on metoprolol, his beta-adrenergic receptors are blocked, which can render standard epinephrine less effective (evidenced by his lack of compensatory tachycardia). In such refractory cases, intravenous glucagon is administered because it increases intracellular cAMP and provides inotropic and chronotropic effects independent of beta-receptors. Finally, if the patient remains in shock despite these interventions, a continuous intravenous epinephrine infusion is initiated to maintain perfusion.

Adım Adım Çözüm

1
Diagnose the acute condition based on the clinical presentation.
The patient is experiencing severe anaphylactic shock.
Sudden onset of dyspnea, angioedema, urticaria, wheezing, and profound hypotension after allergen exposure (seafood) confirm anaphylaxis.
2
Identify the critical home medication influencing the presentation.
The patient is taking metoprolol, a beta-blocker.
The relative bradycardia (pulse 62/min) in the setting of severe distributive shock suggests beta-blockade, which blunts the compensatory tachycardic response and can render standard epinephrine doses ineffective.
3
Select the immediate first-line pharmacologic intervention.
Administer intramuscular epinephrine.
Intramuscular epinephrine is the life-saving first step for all anaphylaxis patients to halt mast cell degranulation, regardless of concurrent beta-blocker use.
4
Determine the next step for persistent distributive shock.
Administer a rapid intravenous bolus of 0.9% sodium chloride.
Aggressive fluid resuscitation is required to counteract the massive capillary leak and vasodilation that occurs in anaphylaxis.
5
Select the specific antidote for beta-blocker-associated refractory anaphylaxis.
Administer intravenous glucagon.
Glucagon bypasses the blocked beta-adrenergic receptors to increase intracellular cAMP, providing essential inotropic and chronotropic support as well as bronchodilation.
6
Identify the final escalation step if the patient remains in shock.
Initiate a continuous intravenous epinephrine infusion.
When intermittent intramuscular doses, fluids, and glucagon fail to restore perfusion, a continuous vasopressor infusion is necessary.

Anahtar Kavram

The correct escalation sequence for managing refractory anaphylaxis in a patient on beta-blockers is intramuscular epinephrine, followed by intravenous fluid resuscitation, intravenous glucagon, and finally continuous intravenous epinephrine infusion.
Tahmini Süre:1m 30s
Soru 68Soru →

A 67-year-old man comes to the cardiology clinic for a follow-up evaluation. Over the past 6 months, he has experienced four episodes of severe palpitations, shortness of breath, and fatigue, each lasting up to 12 hours. He has a history of hypertension, type 2 diabetes mellitus, and paroxysmal atrial fibrillation. Current medications include metoprolol succinate, apixaban, rosuvastatin, and lisinopril. His blood pressure is 132/82132/82 mmHg, and his pulse is 7878/min and irregularly irregular. An electrocardiogram confirms atrial fibrillation with a ventricular rate of 7676/min. The patient is highly symptomatic during his episodes, and after discussing the risks and benefits, the physician decides to initiate oral amiodarone for rhythm control. Which of the following parameters should be evaluated prior to initiating this therapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Hepatic function panel; Thyroid-stimulating hormone level

Cevap

The necessary baseline parameters for amiodarone initiation are a hepatic function panel and a thyroid-stimulating hormone (TSH) level.
Amiodarone is a highly efficacious class III antiarrhythmic agent but is associated with multi-organ toxicity, necessitating comprehensive baseline and ongoing monitoring. Amiodarone contains iodine and can cause both hypothyroidism (via the Wolff-Chaikoff effect) and hyperthyroidism (via the Jod-Basedow phenomenon); therefore, a baseline thyroid-stimulating hormone (TSH) level is universally required. Additionally, it can cause transient, asymptomatic transaminitis or severe hepatotoxicity, mandating a baseline hepatic function panel. Standard baseline testing also includes an electrocardiogram and a standard chest radiograph.

Adım Adım Çözüm

1
Analyze the clinical scenario and the planned pharmacological intervention.
The patient is being started on oral amiodarone for the management of highly symptomatic paroxysmal atrial fibrillation.
Identifying the specific medication allows for the anticipation of its adverse effect profile and the determination of standard baseline monitoring requirements.
2
Identify the standard baseline monitoring parameters required for amiodarone.
Due to its multi-organ toxicity, amiodarone requires a baseline electrocardiogram, chest radiograph, thyroid-stimulating hormone (TSH) level, and hepatic function panel.
Amiodarone can induce QTc prolongation, interstitial pneumonitis, thyroid dysfunction (hypo- and hyperthyroidism), and hepatotoxicity.
3
Evaluate the incorrect options against the patient's current medication regimen to rule out inappropriate testing.
Routine CK monitoring is unnecessary because rosuvastatin does not carry the same CYP3A4 interaction risk as simvastatin. PT/INR monitoring is useless for evaluating apixaban. A baseline HRCT is excessively advanced imaging compared to a standard chest radiograph.
Understanding distinct pharmacokinetic interactions and appropriate diagnostic test sequencing prevents the ordering of unnecessary, high-cost, or low-yield investigations.

Anahtar Kavram

Baseline monitoring prior to amiodarone initiation mandates evaluation of pulmonary function (chest radiograph), thyroid function (TSH/Free T4), hepatic function (AST/ALT/bilirubin), and an electrocardiogram.
Tahmini Süre:1m 30s
Soru 69Soru →

A 62-year-old woman is evaluated in the emergency department for right lower extremity swelling and pain that began 2 days ago. Her past medical history is significant for hypertension, type 2 diabetes mellitus, and end-stage renal disease requiring hemodialysis three times a week. Vital signs include a temperature of 37.1°C (98.8°F), blood pressure of 142/86 mmHg, pulse of 88/min, and respiratory rate of 14/min. Physical examination reveals a swollen, tender, and erythematous right calf. A comprehensive metabolic panel is notable for a blood urea nitrogen of 42 mg/dL and a serum creatinine of 5.8 mg/dL. Compression ultrasonography of the right lower extremity demonstrates a noncompressible right popliteal vein. Which of the following is the most appropriate initial pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous unfractionated heparin

Cevap

Intravenous unfractionated heparin
The correct intervention is intravenous unfractionated heparin. This patient has an acute deep vein thrombosis (DVT) and requires immediate systemic anticoagulation. Because she has end-stage renal disease (ESRD) on hemodialysis, medications that are primarily cleared by the kidneys are contraindicated due to the risk of drug accumulation and severe bleeding. Unfractionated heparin undergoes hepatic metabolism and reticuloendothelial clearance, making it the preferred and safest initial parenteral anticoagulant for patients with a creatinine clearance of less than 30 mL/min.

Adım Adım Çözüm

1
Diagnose the acute condition based on clinical presentation and ultrasound findings.
The patient has an acute right popliteal deep vein thrombosis (DVT).
Swelling, pain, erythema, and a noncompressible vein on compression ultrasonography are diagnostic of an acute DVT.
2
Identify significant comorbidities that affect pharmacologic management.
The patient has end-stage renal disease (ESRD) on hemodialysis.
Renal failure alters the clearance of many common anticoagulants, necessitating alternative selections.
3
Select the appropriate anticoagulant that is safe for immediate use in ESRD.
Intravenous unfractionated heparin is selected.
Unlike low-molecular-weight heparins or certain direct oral anticoagulants, unfractionated heparin is hepatically cleared and safe to use in patients with severe renal impairment.

Anahtar Kavram

Selection of safe initial anticoagulation in patients with end-stage renal disease
Soru 70Soru →

A 72-year-old man comes to the clinic to establish care. He was recently diagnosed with paroxysmal atrial fibrillation and was started on apixaban for stroke prophylaxis. Due to highly symptomatic palpitations despite maximum tolerated beta-blocker therapy, the decision is made today to initiate oral amiodarone for rhythm control. He has a history of essential hypertension but no other major medical conditions. Which of the following tests are indicated for baseline and routine ongoing monitoring of this new antiarrhythmic therapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Thyroid-stimulating hormone (TSH) level; Hepatic function panel; Chest radiograph and pulmonary function tests

Cevap

The required baseline and ongoing monitoring tests for amiodarone therapy include a thyroid-stimulating hormone (TSH) level, a hepatic function panel, and a combination of a chest radiograph and pulmonary function tests.
Amiodarone is a highly effective Class III antiarrhythmic agent but has a complex adverse effect profile due to its high iodine content, lipophilicity, and extensive tissue accumulation. It is well-documented to cause thyroid dysfunction (both hyperthyroidism and hypothyroidism), hepatotoxicity, and potentially fatal pulmonary toxicity (such as interstitial pneumonitis and pulmonary fibrosis). Consequently, standard-of-care guidelines mandate that before initiating therapy, and periodically thereafter, patients must undergo monitoring with a thyroid-stimulating hormone (TSH) level, a hepatic function panel, and a pulmonary evaluation consisting of a chest radiograph and pulmonary function tests (alongside electrocardiograms).

Adım Adım Çözüm

1
Identify the prescribed high-risk medication and its organ toxicity profile.
The patient is starting amiodarone, which is known to cause significant thyroid, hepatic, and pulmonary toxicity over time.
Recognizing the broad toxicity profile of amiodarone determines the specific laboratory and diagnostic monitoring parameters required.
2
Select the appropriate guideline-concordant tests for baseline and periodic surveillance.
Standard monitoring protocols mandate baseline and routine evaluation with TFTs, LFTs, a chest radiograph, and PFTs (along with an ECG).
Regular surveillance detects early, asymptomatic organ dysfunction, allowing for timely medication adjustment or discontinuation before irreversible damage occurs.
3
Exclude unnecessary or inappropriate tests based on the patient's presentation and concurrent medication regimen.
Routine HRCT of the chest and a coagulation profile are excluded.
HRCT is indicated only if symptoms of pulmonary toxicity develop. Coagulation monitoring is inappropriate because the patient is taking apixaban, which does not require PT/INR surveillance, unlike warfarin.

Anahtar Kavram

Baseline and ongoing monitoring for amiodarone toxicity
Tahmini Süre:1m 0s
Soru 71Soru →

A 32-year-old man is brought to the emergency department after a motor vehicle collision. Radiographs reveal a closed, mid-shaft fracture of the right tibia, and the patient is admitted for planned orthopedic fixation. Six hours later, he complains of severe, unrelenting right leg pain that is significantly worse than upon initial presentation. The pain is not relieved by intravenous morphine. On physical examination, the right leg is markedly swollen, tense, and exquisitely tender to palpation. There is severe pain elicited with passive dorsiflexion of the right toes. Distal pulses in the right lower extremity are currently palpable. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Emergent four-compartment surgical fasciotomy

Cevap

Emergent four-compartment surgical fasciotomy
This patient's clinical presentation—severe pain out of proportion to the apparent injury, poor response to opioid analgesia, a tense and swollen limb, and exquisite pain with passive stretch following a tibial fracture—is the classic manifestation of acute compartment syndrome. Acute compartment syndrome is a surgical emergency caused by elevated pressure within a closed fascial space, leading to compromised tissue perfusion. Because irreversible muscle and nerve necrosis can occur within hours, the most appropriate next step in management is an emergent four-compartment surgical fasciotomy to decompress the leg. Note that the presence of distal pulses does not rule out compartment syndrome, as arterial flow is typically maintained until the latest stages of the condition.

Adım Adım Çözüm

1
Analyze the patient's symptoms and history.
The patient has a recent long bone fracture (tibia) and develops severe pain out of proportion to the injury, not relieved by standard analgesics.
Tibial fractures are the most common cause of acute compartment syndrome, making the history highly suspicious.
2
Interpret the physical examination findings.
The leg is tense and swollen, with severe pain upon passive muscle stretch (dorsiflexion of toes). Palpable pulses are still present.
Pain with passive stretch and a tense compartment are the earliest and most sensitive clinical signs of acute compartment syndrome. Pulses typically remain intact until very late in the ischemic process.
3
Determine the appropriate procedural intervention.
Identify that emergent surgical decompression is required to relieve the compartment pressure.
Failure to immediately perform a fasciotomy leads to irreversible muscle and nerve ischemia.

Anahtar Kavram

Diagnosis and acute surgical management of compartment syndrome
Tahmini Süre:45s
Soru 72Soru →

A 74-year-old woman is brought to the emergency department from a skilled nursing facility due to fever and altered mental status over the past 24 hours. Her medical history includes hypertension, type 2 diabetes mellitus, and osteoarthritis.

Vitals:
Temperature: 39.6∘C39.6^{\circ}\text{C} (103.3∘F103.3^{\circ}\text{F})
Blood pressure: 82/52 mmHg82/52 \text{ mmHg}
Heart rate: 128/min128/\text{min}
Respiratory rate: 24/min24/\text{min}
Oxygen saturation: 94% on room air

Physical examination reveals profound lethargy, scleral icterus, and severe right upper quadrant abdominal tenderness with guarding.

Laboratory studies:
Leukocyte count: 24,500/mm324,500/\text{mm}^3 (15% bands)
Hemoglobin: 10.2 g/dL10.2 \text{ g/dL}
Platelet count: 88,000/mm388,000/\text{mm}^3
Total bilirubin: 7.8 mg/dL7.8 \text{ mg/dL}
Direct bilirubin: 6.1 mg/dL6.1 \text{ mg/dL}
Alkaline phosphatase: 640 U/L640 \text{ U/L}
Aspartate aminotransferase: 185 U/L185 \text{ U/L}
Alanine aminotransferase: 210 U/L210 \text{ U/L}
Prothrombin time: 22 seconds22 \text{ seconds}
INR: 2.32.3

Right upper quadrant ultrasound demonstrates a dilated common bile duct measuring 1.4 cm with an obstructing echogenic focus. The gallbladder is present but lacks wall thickening or pericholecystic fluid.

Aggressive intravenous fluid resuscitation and broad-spectrum antibiotics are immediately initiated. Following the infusion of 2 liters of crystalloid, her blood pressure is 98/60 mmHg98/60 \text{ mmHg} and her heart rate is 105/min105/\text{min}.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Endoscopic retrograde cholangiopancreatography

Cevap

Endoscopic retrograde cholangiopancreatography
This patient presents with Reynolds pentad (fever, right upper quadrant pain, jaundice, hypotension, and altered mental status), which is pathognomonic for acute severe (suppurative) cholangitis. Ultrasound confirms the diagnosis by showing common bile duct dilation and an obstructing stone. The initial management consists of hemodynamic stabilization with intravenous fluids and broad-spectrum antibiotics. However, medical therapy alone is insufficient for severe cholangitis; emergent biliary decompression is required to remove the infected bile and obstructing stone. Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is the standard of care and the most appropriate procedural intervention to rapidly decrease biliary pressure and control the source of sepsis.

Adım Adım Çözüm

1
Identify the clinical syndrome based on the presentation and vital signs.
The patient has fever, jaundice, right upper quadrant pain (Charcot's triad), hypotension, and altered mental status, completing Reynolds pentad.
Recognizing Reynolds pentad is critical for diagnosing acute severe (suppurative) cholangitis.
2
Evaluate the diagnostic data.
Labs show leukocytosis, conjugated hyperbilirubinemia, and elevated alkaline phosphatase. Ultrasound confirms a dilated common bile duct with a gallstone.
This confirms the etiology is an obstructing choledocholithiasis causing biliary stasis and ascending infection.
3
Determine the definitive procedural intervention.
The patient requires emergent biliary decompression via endoscopic retrograde cholangiopancreatography (ERCP).
While IV fluids and antibiotics provide initial stabilization, the source of infection (obstructed, purulent biliary tree) must be physically drained to prevent mortality.

Anahtar Kavram

Emergent biliary decompression via ERCP is the definitive procedural management for acute severe cholangitis (Reynolds pentad) once initial hemodynamic stabilization is underway.
Soru 73Soru →

An octogenarian patient with a history of moderate dementia is medically stable for discharge following a prolonged admission for urosepsis. During the hospital course, the patient experienced severe deconditioning and is now unable to perform basic mobility tasks without maximal physical assistance. The primary inpatient team determines that the patient requires transition to a skilled nursing facility (SNF) to receive structured physical therapy and skilled nursing oversight. To ensure a compliant and safe care transition that minimizes readmission risk, arrange the following multidisciplinary and physician actions in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with assessing specific clinical needs, followed by verifying payer eligibility, selecting a facility with the surrogate, transmitting records for acceptance, and concluding with a clinician-to-clinician handoff.
A safe and compliant care transition follows a systematic workflow. First, the clinical team must assess the patient to identify specific skilled needs. Next, case management verifies that these needs and the hospital course meet payer criteria for post-acute coverage. Once eligibility is confirmed, the healthcare proxy is engaged to select preferred facilities based on location and capability. Clinical records are then sent to these selected facilities so their medical directors can approve the admission. Finally, once a bed is secured and transfer is pending, the discharging physician conducts a direct verbal handoff with the receiving clinician to ensure continuity of care.

Adım Adım Çözüm

1
Assess post-acute skilled needs via the multidisciplinary team.
Clinical requirements for placement (e.g., daily PT/OT, nursing needs) are clearly delineated.
Establishes the medical necessity required to initiate the disposition planning process.
2
Verify regulatory and payer eligibility.
Confirmation that the patient qualifies financially and legally for the SNF level of care.
Prevents inappropriate referrals that would result in out-of-pocket costs or denial of care.
3
Engage the proxy for facility selection.
A targeted list of preferred, in-network facilities is created.
Ensures shared decision-making and respects family preferences for care locations once eligibility is known.
4
Transmit clinical documentation to selected facilities.
Receiving facilities review the patient's case and provide formal medical acceptance.
SNFs are legally required to review recent notes to confirm they have the clinical capacity to manage the patient safely.
5
Perform clinician-to-clinician verbal handoff.
Active issues, pending labs, and care nuances are communicated directly.
Minimizes medical errors and ensures continuity of care during the physical transfer.

Anahtar Kavram

Safe disposition to a post-acute care facility requires a systematic workflow: identifying specific care needs, verifying regulatory eligibility, shared facility selection, obtaining formal medical acceptance, and finalizing with a direct clinical handoff.
Soru 74Soru →

Match each clinical presentation of a patient experiencing swallowing difficulties or related symptoms with the most appropriate, guideline-indicated next step in the diagnostic workup.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 72-year-old man with long-standing heartburn reports progressive dysphagia starting with solids and now involving liquids, accompanied by a 6-kg (13.2-lb) weight loss.
A 35-year-old woman presents with intermittent difficulty swallowing both solids and liquids. A recent upper endoscopy was normal, showing no mucosal inflammation or mechanical obstruction.
A 65-year-old man who recently suffered a middle cerebral artery stroke reports frequent coughing, choking, and nasal regurgitation immediately upon initiating a swallow.
A 48-year-old woman complains of a chronic nocturnal cough. Chest radiography and upper endoscopy are unremarkable, and she has not responded to an 8-week trial of proton pump inhibitors.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations map to their respective diagnostic tests based on distinguishing oropharyngeal from esophageal dysphagia, and structural lesions from motility disorders. Progressive solid-to-liquid dysphagia with alarm symptoms requires upper endoscopy. Dysphagia to both solids and liquids with a normal endoscopy requires esophageal manometry. Stroke with immediate choking requires a modified barium swallow. Refractory atypical GERD symptoms with normal endoscopy require pH monitoring.
The correct pairings align the clinical presentation with the most accurate and safe sequential diagnostic test, avoiding premature functional testing while prioritizing ruling out malignancy or life-threatening aspiration.

Adım Adım Çözüm

1
Analyze the timing of the symptoms relative to the act of swallowing.
Immediate coughing/choking indicates an oropharyngeal etiology, while delayed sensation of food sticking indicates an esophageal etiology.
Oropharyngeal dysphagia requires dynamic functional testing (modified barium swallow), whereas esophageal dysphagia typically requires mucosal evaluation (endoscopy).
2
Evaluate the progression of food types causing dysphagia in esophageal presentations.
Solids progressing to liquids suggests a mechanical obstruction (e.g., stricture, cancer), whereas equal difficulty with solids and liquids from onset suggests a motility disorder.
This distinction determines whether the primary diagnostic focus should be structural visualization (endoscopy) or functional pressure measurement (manometry).
3
Assess the sequence of prior testing to determine the next best step.
If structural causes are suspected, endoscopy is first. If endoscopy is already performed and normal, functional testing (manometry or pH monitoring) is the next sequential step.
Test sequencing must proceed from ruling out life-threatening mechanical/structural issues to confirming functional diagnoses.

Anahtar Kavram

Diagnostic sequencing for dysphagia categorizes symptoms into oropharyngeal versus esophageal, and structural versus motility disorders, to correctly sequence modified barium swallow, endoscopy, manometry, or pH monitoring.
Soru 75Soru →

A 56-year-old man is brought to the emergency department by ambulance after vomiting a large amount of bright red blood. He has a history of alcohol use disorder and compensated cirrhosis. On arrival, he is lethargic but localizes to pain and maintains his airway. Blood pressure is 88/55 mm Hg, and pulse is 118/min. Physical examination reveals scleral icterus, palmar erythema, and a distended abdomen with shifting dullness. Two large-bore peripheral intravenous lines are placed, and fluid resuscitation with isotonic crystalloid is initiated. Laboratory studies show:

Laboratory ParameterResult
Hemoglobin8.2 g/dL
Platelet count75,000/mm³
Prothrombin time18 seconds
INR1.8

Which of the following pharmacologic interventions are most appropriate for this patient at this time? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Intravenous octreotide; Intravenous ceftriaxone

Cevap

The most appropriate interventions are intravenous octreotide and intravenous ceftriaxone.
In the setting of suspected acute variceal hemorrhage, initial pharmacologic therapy focuses on reducing portal venous pressure and preventing severe infectious complications. Intravenous octreotide, a somatostatin analog, inhibits the release of vasodilator hormones (such as glucagon), leading to splanchnic vasoconstriction and a subsequent decrease in portal inflow and variceal pressure. Concurrently, bacterial infections (particularly spontaneous bacterial peritonitis) are a major trigger and complication of variceal bleeding in cirrhosis. The administration of prophylactic antibiotics, typically intravenous ceftriaxone, has been definitively shown to reduce both rebleeding rates and overall mortality, making it a mandatory initial intervention.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and vital signs.
The patient has signs of hemorrhagic shock (hypotension, tachycardia) secondary to acute upper gastrointestinal bleeding, highly suspicious for variceal hemorrhage given his history of cirrhosis and stigmata of chronic liver disease.
Establishing the severity and likely etiology of the bleeding dictates the immediate resuscitative and pharmacologic priorities.
2
Evaluate the indication for portal pressure reduction and infection prophylaxis.
Octreotide must be initiated to reduce splanchnic blood flow. Ceftriaxone must be initiated because cirrhotic patients with GI bleeding are at high risk for spontaneous bacterial peritonitis and bacteremia.
These two interventions are the cornerstone of initial medical management for suspected variceal bleeding and have been shown to reduce mortality.
3
Assess standard treatments that might be contraindicated in this specific acute setting.
Propranolol, fresh frozen plasma (FFP), and enteral lactulose are rejected.
Propranolol causes shock in acute bleeding; FFP increases portal pressure without correcting the complex cirrhotic coagulopathy; and enteral lactulose poses an aspiration risk during active hematemesis.

Anahtar Kavram

The initial pharmacologic management of acute variceal bleeding in cirrhosis requires splanchnic vasoconstrictors (e.g., octreotide) to decrease portal pressure and prophylactic antibiotics (e.g., ceftriaxone) to prevent mortality-increasing infections.
Soru 76Soru →

A 5252-year-old woman is brought to the emergency department for sudden-onset severe shortness of breath, left-sided chest pain, and lightheadedness. She underwent a right total knee arthroplasty 1414 days ago. On arrival, she is visibly distressed, diaphoretic, and confused.

Vital signs are:
Temperature: 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F)
Blood pressure: 72/4572/45 mmHg
Heart rate: 138138/min
Respiratory rate: 3434/min
SpO2SpO_2: 84%84\% on 1515 L/min via non-rebreather mask

Physical examination reveals pronounced jugular venous distention. Lung auscultation is clear bilaterally. Heart sounds are rapid with a loud P2P_2, but no murmurs are appreciated. The right lower extremity is mildly edematous compared to the left.

Point-of-care echocardiography demonstrates a severely dilated right ventricle with a flattened interventricular septum bowing into the left ventricle, diminished right ventricular free wall motion, and a small, hyperkinetic left ventricle.

Which of the following are the most appropriate initial steps in the stabilization of this patient? (Select 2)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Initiation of a continuous norepinephrine infusion; Administration of systemic alteplase

Cevap

The most appropriate initial stabilization steps are the initiation of a continuous norepinephrine infusion and the administration of systemic alteplase.
This patient presents with a massive pulmonary embolism (PE), characterized by acute PE causing hemodynamic instability (obstructive shock). The clinical presentation of sudden dyspnea following orthopedic surgery combined with point-of-care echocardiography showing right ventricular (RV) dilation and septal flattening (the 'D-sign') provides sufficient diagnostic certainty to initiate life-saving empiric therapy. The immediate goals of stabilization are to support systemic perfusion and relieve RV pressure overload. Norepinephrine is the vasopressor of choice because it increases systemic vascular resistance (improving RV coronary perfusion) and provides inotropic support to the failing RV without significantly increasing pulmonary vascular resistance. Concurrently, systemic thrombolysis (e.g., alteplase) is indicated in massive PE to rapidly reduce the pulmonary arterial clot burden, decrease RV afterload, and restore cardiac output.

Adım Adım Çözüm

1
Identify the underlying pathology.
The patient's recent surgery, acute severe dyspnea, and profound hypotension indicate massive pulmonary embolism (PE) causing obstructive shock.
Recognizing the exact mechanism of shock dictates the specialized stabilization sequence required.
2
Evaluate point-of-care ultrasound findings.
Echocardiography shows severe right ventricular (RV) dilation and septal bowing (D-sign), confirming acute right heart strain and impending cardiovascular collapse.
In hemodynamically unstable patients, bedside ultrasound provides sufficient diagnostic confidence to initiate definitive empiric therapy without risking transport.
3
Determine the appropriate hemodynamic and pharmacological interventions.
Norepinephrine must be started to maintain systemic perfusion and RV coronary blood flow. Concurrently, systemic thrombolysis (alteplase) must be administered to dissolve the clot burden.
Standard resuscitative measures like intubation and aggressive fluid boluses are actively harmful in severe RV failure due to their negative effects on venous return and ventricular interdependence.

Anahtar Kavram

In massive pulmonary embolism with obstructive shock, immediate stabilization relies on vasopressor support (norepinephrine) and reperfusion therapy (thrombolysis) based on bedside clinical and echocardiographic findings, while avoiding therapies that worsen right ventricular hemodynamics (fluids, positive pressure ventilation).
Soru 77Soru →

A 5555-year-old man presents for a health maintenance examination. His calculated 1010-year atherosclerotic cardiovascular disease risk is determined to be 12%12\%. He has no active symptoms, and his baseline low-density lipoprotein cholesterol is 150 mg/dL150\text{ mg/dL}. Following a shared decision-making discussion, the physician prescribes moderate-intensity atorvastatin for primary prevention. The patient is also counseled on dietary modifications and regular aerobic exercise. Assuming the patient experiences no adverse effects, which of the following is the most appropriate next step in monitoring his therapeutic response?

Cevabı ve açıklamayı göster

Cevap: Assess adherence and repeat a fasting lipid panel in 44 to 1212 weeks

Cevap

Assess adherence and repeat a fasting lipid panel in 44 to 1212 weeks
When a patient is started on statin therapy, the maximum low-density lipoprotein (LDL) lowering effect is typically achieved within 44 to 1212 weeks. Therefore, the standard of care is to assess medication adherence and repeat a fasting lipid panel within this 44- to 1212-week window to evaluate therapeutic efficacy. If the LDL goal is met, subsequent monitoring can be spaced out to every 33 to 1212 months.

Adım Adım Çözüm

1
Identify the clinical scenario
An asymptomatic patient is initiating statin therapy for primary cardiovascular prevention.
Determines the baseline status and the purpose of the new medication.
2
Determine the appropriate monitoring protocol
Standard guidelines recommend checking a lipid panel 44 to 1212 weeks after starting a statin.
This timeframe allows the medication to reach its maximum therapeutic effect on lipid levels, enabling accurate assessment of efficacy and patient adherence.

Anahtar Kavram

Monitoring timeline for statin therapy initiation
Tahmini Süre:1m 0s
Soru 78Soru →

A 32-year-old woman is brought to the emergency department by paramedics following a high-speed motor vehicle collision. She was the unrestrained driver of a vehicle that struck a concrete barrier. She complains of severe lower abdominal and pelvic pain. Past medical history is unremarkable. Vital signs reveal a temperature of 36.6°C (97.9°F), blood pressure of 72/40 mm Hg, pulse of 138/min, respirations of 26/min, and oxygen saturation of 96% on supplemental oxygen. She is pale, diaphoretic, and restless. Her airway is patent, and breath sounds are present and equal bilaterally. The abdomen is non-distended but tender in the suprapubic region. A pelvic examination demonstrates mechanical instability with anterior-posterior compression. No active external hemorrhage is noted. Two large-bore intravenous lines are established, and a massive transfusion protocol is initiated. Which of the following is the most urgent next step in the stabilization of this patient?

Cevabı ve açıklamayı göster

Cevap: Application of a circumferential pelvic compression device

Cevap

Application of a circumferential pelvic compression device
In a hemodynamically unstable patient with a suspected pelvic fracture (evidenced by mechanical instability on physical exam and signs of hemorrhagic shock), the immediate priority after securing the airway and breathing is circulatory stabilization. Pelvic fractures can cause massive retroperitoneal bleeding, primarily from the presacral venous plexus and fractured bone ends. Applying a circumferential pelvic compression device (pelvic binder) is the most urgent next step because it mechanically reduces the pelvic volume, promotes a tamponade effect on venous bleeding, and stabilizes bony fragments to prevent further vascular injury. It is a rapid, non-invasive maneuver that should be performed immediately alongside fluid and blood product resuscitation, prior to definitive imaging or surgical interventions.

Adım Adım Çözüm

1
Assess the primary survey (ABCDE) status of the trauma patient.
Airway and Breathing are intact, but Circulation is severely compromised (hypotensive shock).
Life-threatening injuries must be identified and treated in sequence according to ATLS protocols.
2
Identify the likely source of hemorrhagic shock.
The physical examination reveals a mechanically unstable pelvis, highly suggestive of a major pelvic ring disruption with retroperitoneal bleeding.
The pelvis can hold massive amounts of blood, primarily from the presacral venous plexus and fractured cancellous bone.
3
Select the immediate stabilization intervention for the identified source.
A circumferential pelvic compression device (pelvic binder) is indicated.
The binder mechanically stabilizes the fracture, reduces pelvic volume, and promotes a tamponade effect to control life-threatening venous hemorrhage.

Anahtar Kavram

In hemodynamically unstable patients with pelvic fractures, the immediate circulatory stabilization priority is mechanical reduction of the pelvis with a binder to control retroperitoneal venous hemorrhage.
Tahmini Süre:1m 15s
Soru 79Soru →

During a routine follow-up visit at the public health clinic, a physician evaluates an asymptomatic patient who recently began treatment for latent tuberculosis infection. Four weeks ago, the patient had a positive interferon-gamma release assay with a normal chest radiograph, leading to the initiation of daily isoniazid and pyridoxine.

The patient currently reports feeling entirely well, specifically denying fatigue, nausea, vomiting, abdominal pain, jaundice, or changes in urine color.

Recent laboratory studies show the following:
TestResultReference Range
Aspartate aminotransferase (AST)115115 U/L88-4040 U/L
Alanine aminotransferase (ALT)130130 U/L77-5656 U/L
Total bilirubin0.80.8 mg/dL0.10.1-1.21.2 mg/dL

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Continue the current regimen and repeat liver function tests in 22 to 44 weeks

Cevap

Continue the current regimen and repeat liver function tests in 22 to 44 weeks
The correct answer is to continue the current regimen and repeat liver function tests. Isoniazid (INH) is a standard treatment for latent tuberculosis but is well-known to cause hepatotoxicity. However, up to 10%10\%-20%20\% of patients develop a transient, mild elevation in hepatic aminotransferases during the first few months of therapy, a phenomenon termed hepatic adaptation. According to established guidelines, INH therapy should only be discontinued if the aminotransferases (AST or ALT) rise to greater than 33 times the upper limit of normal (ULN) in the presence of symptoms (e.g., nausea, vomiting, abdominal pain, jaundice), or greater than 55 times the ULN even in the absence of symptoms. In this scenario, the patient is entirely asymptomatic and the AST and ALT levels are only about 22 to 33 times the ULN (e.g., ALT is 130130 U/L compared to a normal upper limit of 5656 U/L). Therefore, the threshold for stopping the drug has not been met. The most appropriate clinical decision is to maintain the current medication and repeat the liver function tests in 22 to 44 weeks to ensure the transaminitis resolves or remains stable.

Adım Adım Çözüm

1
Analyze the patient's current symptoms and laboratory findings in the context of their medication regimen.
The patient is taking isoniazid and has mild, asymptomatic transaminitis (AST and ALT are roughly 2.52.5 to 33 times the upper limit of normal).
Establishing the severity and symptomatic nature of the transaminitis is required to apply the correct management algorithm.
2
Apply the standard treatment monitoring guidelines for isoniazid-induced hepatotoxicity.
Guidelines dictate stopping isoniazid only if AST/ALT is > 33 times the upper limit of normal with symptoms, or > 55 times the upper limit of normal without symptoms.
Differentiating between benign hepatic adaptation and true drug-induced liver injury prevents inappropriate discontinuation of a necessary medication.
3
Determine the best next step based on the guideline criteria.
Because the transaminases are < 55 times normal and the patient lacks symptoms, the medication should be continued while scheduling repeat laboratory testing in 22 to 44 weeks.
This strategy safely monitors for progression to severe toxicity while allowing completion of latent tuberculosis treatment if values stabilize or improve.

Anahtar Kavram

Monitoring parameters and thresholds for discontinuation of isoniazid due to hepatotoxicity versus benign hepatic adaptation.
Soru 80Soru →

An emergency department physician is evaluating a 48-year-old man with a 4-hour history of sudden-onset, right-sided pleuritic chest pain and mild dyspnea. He has a history of severe alcohol use disorder. The patient is currently unhoused and sleeps at a local nighttime-only community shelter. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 128/82 mmHg, heart rate of 88/min, and respiratory rate of 16/min. Oxygen saturation is 97% on room air. Physical examination reveals clear lungs bilaterally and a regular heart rhythm. Laboratory studies demonstrate normal renal and hepatic function, and a high-sensitivity cardiac troponin I level within the normal reference range. Computed tomography pulmonary angiography reveals a small segmental pulmonary embolism in the right lower lobe. Echocardiography shows normal right ventricular size and function. The patient is alert, oriented, and demonstrates a clear understanding of his diagnosis. When discussing the treatment plan, he states, 'Just give me the pills so I can get back to the shelter before I lose my bed for the night.' Which of the following is the most appropriate next step in the disposition and management of this patient?

Cevabı ve açıklamayı göster

Cevap: Admit to a general medical floor to initiate anticoagulation and consult social services to arrange a safe care transition

Cevap

Admit to a general medical floor to initiate anticoagulation and consult social services to arrange a safe care transition.
This patient presents with a hemodynamically stable, low-risk pulmonary embolism. While patients with a simplified Pulmonary Embolism Severity Index (sPESI) of 0 are typically candidates for early discharge and outpatient management with direct oral anticoagulants, safe disposition also strictly requires a supportive home environment, reliable communication, and low risk of bleeding. This patient is unhoused, stays in a nighttime-only shelter, and has severe alcohol use disorder. These factors create an unacceptably high risk for medication nonadherence, loss to follow-up, and catastrophic bleeding. Therefore, the most appropriate disposition is admission to a general medical floor. This allows the care team to safely initiate anticoagulation while social services and case management coordinate a secure post-hospital transition, such as a medical respite program.

Adım Adım Çözüm

1
Evaluate the patient's physiological risk profile using an objective severity score.
The simplified Pulmonary Embolism Severity Index (sPESI) is 0, indicating a low physiological mortality risk.
Risk stratification is the first step in determining whether a patient with a pulmonary embolism requires admission or can be managed as an outpatient.
2
Assess the patient's functional capacity and social determinants of health regarding treatment safety.
The patient is unhoused, uses a nighttime-only shelter, and has severe alcohol use disorder, representing severe psychosocial vulnerability.
Safe outpatient anticoagulation requires reliable medication adherence, ability to attend follow-up appointments, and a low risk of uncontrolled bleeding, none of which this patient has.
3
Synthesize objective scores with functional capacity to determine the final disposition.
Despite the low sPESI score, the high psychosocial risk mandates admission to a general medical floor to safely initiate treatment and involve case management.
Objective severity scores must always be contextualized with the patient's living situation and functional ability to ensure a safe care setting transition.

Anahtar Kavram

Safe care setting transitions require synthesizing objective clinical severity scores (e.g., sPESI) with a comprehensive assessment of the patient's functional capacity and social determinants of health.
ÖncekiSayfa 4 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 4 | Examkin